Creative Medical Technology Holdings, Inc. Financing Cash Flow
Creative Medical Technology Holdings, Inc. (CELZ) reported Financing Cash Flow of $4.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $4.46M.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $13.36K, a 99.60% decline year-over-year.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.82M, a 134.47% increase year-over-year.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $7.17M, a 393.23% increase from fiscal 2024.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $1.45M.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$270.95K, a 101.75% decline from fiscal 2022.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $15.47M, a 20.48% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $4.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $4.48M 10-Q · filed 2026-08-07 | $8.30M derived: sum of 3 quarters · filed 2026-08-07 | $8.30M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $13.36K 10-Q · filed 2026-05-08 | $3.83M derived: sum of 2 quarters · filed 2026-05-08 | $3.83M derived: sum of 3 quarters · filed 2026-05-08 | $3.83M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $3.82M derived: sum of 2 quarters · filed 2026-03-20 | $3.82M derived: sum of 3 quarters · filed 2026-08-07 | $7.17M 10-K · filed 2026-03-20 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | $3.35M 10-Q · filed 2025-11-07 | $4.98M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.35M 10-Q · filed 2026-08-07 | $4.98M derived: sum of 3 quarters · filed 2026-08-07 | $4.96M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $3.35M 10-Q · filed 2026-05-08 | $4.98M derived: sum of 2 quarters · filed 2026-05-08 | $4.96M derived: sum of 3 quarters · filed 2026-05-08 | $4.89M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $1.60M derived: sum of 2 quarters · filed 2026-03-20 | $1.54M derived: sum of 3 quarters · filed 2026-03-20 | $1.45M 10-K · filed 2026-03-20 | |
| 2024-09-30 | -$25.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$92.07K derived: sum of 2 quarters · filed 2025-11-07 | -$174.86K 10-Q · filed 2025-11-07 | -$254.04K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$66.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$149.41K 10-Q · filed 2025-08-08 | -$228.59K derived: sum of 3 quarters · filed 2025-08-08 | -$420.37K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | -$82.80K 10-Q · filed 2025-05-09 | -$161.97K derived: sum of 2 quarters · filed 2025-05-09 | -$353.75K derived: sum of 3 quarters · filed 2025-05-09 | -$353.75K derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | -$79.17K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$270.95K derived: sum of 2 quarters · filed 2025-03-14 | -$270.95K derived: sum of 3 quarters · filed 2025-03-14 | -$270.95K 10-K · filed 2025-03-14 | |
| 2023-09-30 | -$191.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$191.78K derived: sum of 2 quarters · filed 2024-11-08 | -$191.78K 10-Q · filed 2024-11-08 | $0.00 10-Q · filed 2023-11-14 | -$191.78K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-08-09 | $12.00 derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-05-10 | $12.00 derived: sum of 3 quarters · filed 2024-05-10 | $15.47M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $12.00 derived: sum of 2 quarters · filed 2024-03-22 | $15.47M derived: sum of 3 quarters · filed 2024-03-22 | $15.47M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $12.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $15.47M derived: sum of 2 quarters · filed 2023-11-14 | $15.47M 10-Q · filed 2023-11-14 | $24.78M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $15.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $15.47M 10-Q · filed 2023-08-11 | $24.78M derived: sum of 3 quarters · filed 2023-08-11 | $27.59M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $9.31M derived: sum of 2 quarters · filed 2023-05-12 | $12.12M derived: sum of 3 quarters · filed 2023-05-12 | $12.22M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $9.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $12.12M derived: sum of 2 quarters · filed 2023-03-31 | $12.22M derived: sum of 3 quarters · filed 2023-03-31 | $12.84M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.92M derived: sum of 2 quarters · filed 2022-11-10 | $3.53M 10-Q · filed 2022-11-10 | $3.79M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $105.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $724.23K 10-Q · filed 2022-08-12 | $976.55K derived: sum of 3 quarters · filed 2022-08-12 | $1.15M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $618.64K 10-Q · filed 2022-05-13 | $870.96K derived: sum of 2 quarters · filed 2022-05-13 | $1.05M derived: sum of 3 quarters · filed 2022-05-13 | $1.17M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $252.32K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $428.02K derived: sum of 2 quarters · filed 2022-03-30 | $548.92K derived: sum of 3 quarters · filed 2022-03-30 | $693.92K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $175.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $296.60K derived: sum of 2 quarters · filed 2021-11-15 | $441.60K 10-Q · filed 2021-11-15 | $624.44K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $120.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $265.90K 10-Q · filed 2021-08-16 | $448.74K derived: sum of 3 quarters · filed 2021-08-16 | $761.15K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $145.00K 10-Q · filed 2021-05-17 | $327.84K derived: sum of 2 quarters · filed 2021-05-17 | $640.25K derived: sum of 3 quarters · filed 2021-05-17 | $754.25K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $182.84K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $495.25K derived: sum of 2 quarters · filed 2021-03-17 | $609.25K derived: sum of 3 quarters · filed 2021-03-17 | $997.68K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $312.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $426.40K derived: sum of 2 quarters · filed 2020-11-13 | $814.84K 10-Q · filed 2020-11-13 | $1.24M derived: sum of 4 quarters · filed 2020-11-13 | |
| 2019-06-30 | $114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $502.44K 10-Q · filed 2020-08-14 | $929.29K derived: sum of 3 quarters · filed 2020-08-14 | $1.35M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $388.44K 10-Q · filed 2020-05-15 | $815.29K derived: sum of 2 quarters · filed 2020-05-15 | $1.23M derived: sum of 3 quarters · filed 2020-05-15 | $1.48M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $426.86K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $846.12K derived: sum of 2 quarters · filed 2020-04-06 | $1.09M derived: sum of 3 quarters · filed 2020-04-06 | $1.34M 10-K · filed 2020-04-06 | |
| 2018-09-30 | $419.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $662.22K derived: sum of 2 quarters · filed 2019-11-14 | $915.77K 10-Q · filed 2019-11-14 | $1.03M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $242.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $496.51K 10-Q · filed 2019-08-13 | $611.71K derived: sum of 3 quarters · filed 2019-08-13 | $702.21K derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-03-31 | $253.55K 10-Q · filed 2019-05-20 | $368.75K derived: sum of 2 quarters · filed 2019-05-20 | $459.25K derived: sum of 3 quarters · filed 2019-05-20 | $835.00K derived: sum of 4 quarters · filed 2019-05-20 | |
| 2017-12-31 | $115.20K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $205.70K derived: sum of 2 quarters · filed 2019-04-01 | $581.45K derived: sum of 3 quarters · filed 2019-04-01 | $681.45K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $90.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $466.25K derived: sum of 2 quarters · filed 2018-11-14 | $566.25K 10-Q · filed 2018-11-14 | $940.06K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $375.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $475.75K 10-Q · filed 2018-08-14 | $849.56K derived: sum of 3 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $100.00K 10-Q · filed 2018-08-03 | $473.81K derived: sum of 2 quarters · filed 2018-08-03 | |||
| 2016-12-31 | $373.81K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $677.00K 10-K · filed 2018-03-29 | |||
| 2016-09-30 | $303.19K 10-Q · filed 2017-11-13 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $1.40K derived: sum of 2 quarters · filed 2016-05-13 | $3.90K derived: sum of 3 quarters · filed 2016-05-13 | $8.90K derived: sum of 4 quarters · filed 2016-05-13 | |
| 2015-12-31 | $1.40K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $3.90K derived: sum of 2 quarters · filed 2016-04-14 | $8.90K derived: sum of 3 quarters · filed 2016-04-14 | $13.90K 10-K · filed 2016-04-14 | |
| 2015-09-30 | $2.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $7.50K derived: sum of 2 quarters · filed 2015-11-09 | $12.50K 10-Q · filed 2015-11-09 | $17.50K derived: sum of 4 quarters · filed 2016-05-13 | |
| 2015-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $10.00K 10-Q · filed 2015-08-13 | $15.00K derived: sum of 3 quarters · filed 2016-05-13 | $17.65K derived: sum of 4 quarters · filed 2016-05-13 | |
| 2015-03-31 | $5.00K 10-Q · filed 2016-05-13 | $10.00K derived: sum of 2 quarters · filed 2016-05-13 | $12.65K derived: sum of 3 quarters · filed 2016-05-13 | $17.90K derived: sum of 4 quarters · filed 2016-05-13 | |
| 2014-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | $7.65K derived: sum of 2 quarters · filed 2016-04-14 | $12.90K derived: sum of 3 quarters · filed 2016-04-14 | $17.90K 10-K · filed 2016-04-14 | |
| 2014-09-30 | $2.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $7.90K derived: sum of 2 quarters · filed 2015-11-09 | $12.90K 10-Q · filed 2015-11-09 | $17.17K derived: sum of 4 quarters · filed 2015-11-09 | |
| 2014-06-30 | $5.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $10.25K 10-Q · filed 2015-08-13 | $14.52K derived: sum of 3 quarters · filed 2015-08-13 | $18.20K derived: sum of 4 quarters · filed 2015-08-13 | |
| 2014-03-31 | $5.00K 10-Q · filed 2015-05-08 | $9.27K derived: sum of 2 quarters · filed 2015-05-08 | $12.95K derived: sum of 3 quarters · filed 2015-05-08 | $18.65K derived: sum of 4 quarters · filed 2015-05-08 | |
| 2013-12-31 | $4.27K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $7.95K derived: sum of 2 quarters · filed 2015-02-27 | $13.65K derived: sum of 3 quarters · filed 2015-02-27 | $22.50K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $3.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $9.38K derived: sum of 2 quarters · filed 2014-11-12 | $18.23K 10-Q · filed 2014-11-12 | $21.48K derived: sum of 4 quarters · filed 2014-11-12 | |
| 2013-06-30 | $5.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $14.55K 10-Q · filed 2014-08-08 | $17.80K derived: sum of 3 quarters · filed 2014-08-08 | $22.00K derived: sum of 4 quarters · filed 2014-08-08 | |
| 2013-03-31 | $8.85K 10-Q · filed 2014-05-13 | $12.10K derived: sum of 2 quarters · filed 2014-05-13 | $16.30K derived: sum of 3 quarters · filed 2014-05-13 | $18.80K derived: sum of 4 quarters · filed 2014-05-13 | |
| 2012-12-31 | $3.25K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $7.45K derived: sum of 2 quarters · filed 2014-03-17 | $9.95K derived: sum of 3 quarters · filed 2014-03-17 | $16.45K 10-K · filed 2014-03-17 | |
| 2012-12-03 | $16.45K 10-K · filed 2013-03-15 | ||||
| 2012-09-30 | $4.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $6.70K derived: sum of 2 quarters · filed 2013-11-13 | $13.20K 10-Q · filed 2013-11-13 | $13.20K derived: sum of 4 quarters · filed 2013-11-13 | |
| 2012-06-30 | $2.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $9.00K 10-Q · filed 2013-08-07 | $9.00K derived: sum of 3 quarters · filed 2013-08-07 | $15.00K derived: sum of 4 quarters · filed 2013-08-07 | |
| 2012-03-31 | $6.50K 10-Q · filed 2013-05-07 | $6.50K derived: sum of 2 quarters · filed 2013-05-07 | $12.50K derived: sum of 3 quarters · filed 2013-05-07 | $17.50K derived: sum of 4 quarters · filed 2013-05-07 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $6.00K derived: sum of 2 quarters · filed 2013-03-15 | $11.00K derived: sum of 3 quarters · filed 2013-03-15 | $14.65K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $11.00K derived: sum of 2 quarters · filed 2012-11-07 | $14.65K 10-Q · filed 2012-11-07 | $17.65K derived: sum of 4 quarters · filed 2012-11-07 | |
| 2011-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $8.65K 10-Q · filed 2012-08-09 | $11.65K derived: sum of 3 quarters · filed 2012-08-09 | $17.65K derived: sum of 4 quarters · filed 2012-08-09 | |
| 2011-03-31 | $3.65K 10-Q · filed 2012-05-11 | $6.65K derived: sum of 2 quarters · filed 2012-05-11 | $12.65K derived: sum of 3 quarters · filed 2012-05-11 | ||
| 2010-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-26 | $9.00K derived: sum of 2 quarters · filed 2012-03-26 | $13.50K 10-K · filed 2012-03-26 | ||
| 2010-09-30 | $6.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-10-31 | $10.50K 10-Q · filed 2011-10-31 | |||
| 2010-06-30 | $4.50K 10-Q/A · filed 2011-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |